Download FREE Report Sample
Download Free samplemRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
mRNA Cancer Vaccines and Therapeutics Market contains market size and forecasts of mRNA Cancer Vaccines and Therapeutics in Global, including the following market information:
Global mRNA Cancer Vaccines and Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global mRNA Cancer Vaccines and Therapeutics market was valued at 144.5 million in 2021 and is projected to reach US$ 465.2 million by 2028, at a CAGR of 18.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adeno Carcinomas Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of mRNA Cancer Vaccines and Therapeutics include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the mRNA Cancer Vaccines and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Cancer Vaccines and Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, by Type, 2021 (%)
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Global mRNA Cancer Vaccines and Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, by Application, 2021 (%)
Infectious Disease
Cancer
Others
Global mRNA Cancer Vaccines and Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies mRNA Cancer Vaccines and Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies mRNA Cancer Vaccines and Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
